Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 25Fallopian Tube Neoplasms 10Uterine Cervical Neoplasms 9Endometrial Neoplasms 6Carcinoma, Ovarian Epithelial 6Urinary Bladder Neoplasms 4Stomach Neoplasms 4Recurrence 4Peritoneal Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Breast Neoplasms 4Triple Negative Breast Neoplasms 3Prostatic Neoplasms 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Hepatocellular 2Tumor Virus Infections 1Sarcoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Melanoma 1Lung Neoplasms 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Cancer 1Gallbladder Neoplasms 1Dysgerminoma 1Colorectal Neoplasms 1Cholangiocarcinoma 1Cervical Adenocarcinoma 1

Interventions

Cisplatin 4sintilimab 2Radiation Dose Hypofractionation 1Radiation 1Platinum 1Irinotecan 1Immunotherapy 1Brachytherapy 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Carcinoma × Albumin-Bound Paclitaxel × Gynecologic × Clear all
NCT06391190 2024-04-30

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

RenJi Hospital

Phase 1/2 Recruiting
20 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡